Arlene B. Chapman
-
- Hormonal Regulation and Hypertension 24
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism 16
- Nephrology top 2%
- Renal Diseases and Glomerulopathies 8
- Obstetrics and Gynecology top 2%
-
- Blood Pressure and Hypertension Studies 12
- Renin-Angiotensin System Studies 8
-
- Metabolomics and Mass Spectrometry Studies 10
- Receptor Mechanisms and Signaling 7
-
- MRI in cancer diagnosis 6
- Co-authors
- Stephen T. TurnerEric BoerwinkleGary L. SchwartzJohn G. GumsJulie A. JohnsonRhonda M. Cooper‐DeHoffYan GongRobert W. Schrier
- Partner nations
- United StatesNetherlandsFrance
In The Last Decade
Arlene B. Chapman
87 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 122
- Endocrinology, Diabetes and Metabolism 683
- Pharmacology 352
- Nephrology 269
- Obstetrics and Gynecology 282
- Cardiology and Cardiovascular Medicine 788
Countries citing papers authored by Arlene B. Chapman
This map shows the geographic impact of Arlene B. Chapman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arlene B. Chapman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arlene B. Chapman more than expected).
Fields of papers citing papers by Arlene B. Chapman
This network shows the impact of papers produced by Arlene B. Chapman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arlene B. Chapman. The network helps show where Arlene B. Chapman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Arlene B. Chapman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 4 | |
| 5 | 2022 | 21 | |
| 6 | 2022 | 6 | |
| 7 | 2021 | 13 | |
| 8 | 2021 | 8 | |
| 9 | 2019 | 49 | |
| 10 | 2018 | 9 | |
| 11 | 2017 | 6 | |
| 12 | 2014 | 9 | |
| 13 | 2014 | 72 | |
| 14 | 2013 | 11 | |
| 15 | 2010 | 58 | |
| 16 | 2007 | 83 | |
| 17 | 2005 | 56 | |
| 18 | 1997 | 24 | |
| 19 | [100 cases of generalised postoperative peritonitis (author's transl)]. | 1977 | 8 |
| 20 | Effets du furosémide chez les malades en insuffisance rénale aiguë. Diminution du recours aux méthodes de dialyse. | 1972 | 1 |
About Arlene B. Chapman
Arlene B. Chapman is a scholar working on Nephrology, Pharmacology and Endocrinology, Diabetes and Metabolism, having authored 89 papers that have together received 2.6k indexed citations. Recurring topics across this work include Hormonal Regulation and Hypertension (24 papers), Pharmacogenetics and Drug Metabolism (16 papers), Blood Pressure and Hypertension Studies (12 papers), Metabolomics and Mass Spectrometry Studies (10 papers), Renal Diseases and Glomerulopathies (8 papers), Renin-Angiotensin System Studies (8 papers), Receptor Mechanisms and Signaling (7 papers) and MRI in cancer diagnosis (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (683 citations), Pharmacology (352 citations) and Nephrology (269 citations). Arlene B. Chapman has collaborated with scholars based in United States, Netherlands and France. Frequent co-authors include Stephen T. Turner, Eric Boerwinkle, Gary L. Schwartz, John G. Gums, Julie A. Johnson, Rhonda M. Cooper‐DeHoff, Yan Gong, Robert W. Schrier, Amber L. Beitelshees and Lorna G. Moore. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Diabetes Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.